Press Releases
Stay informed with the latest news and updates from the California Institute for Regenerative Medicine (CIRM). For media inquiries or additional information, contact the CIRM communications team at press@cirm.ca.gov. For even more breaking news, visit our blog, The Stem Cellar.
May 1, 2019
CIRM Board Approves Funding for New Clinical Trials in Solid Tumors and Pediatric Disease
CIRM Board Approves Funding for New Clinical Trials in Solid Tumors and Pediatric Disease
March 21, 2019
Stem Cell Agency Awards Almost $4 Million to Develop a Treatment for Spinal Degeneration
Stem Cell Agency Awards Almost $4 Million to Develop a Treatment for Spinal Degeneration
February 21, 2019
Stem Cell Agency Invests in Chemotherapy-Free Approach to Rare But Deadly Childhood Disease
Stem Cell Agency Invests in Chemotherapy-Free Approach to Rare But Deadly Childhood Disease
October 18, 2018
Stem Cell Agency Invests in New Immunotherapy Approach to HIV, Plus Promising Projects Targeting Blindness and Leukemia
Stem Cell Agency Invests in New Immunotherapy Approach to HIV, Plus Promising Projects Targeting Blindness and Leukemia
July 19, 2018
Late-Stage Preclinical Research Targeting Prostate Cancer Gets Almost $4 Million Support from California’s Stem Cell Agency
Late-Stage Preclinical Research Targeting Prostate Cancer Gets Almost $4 Million Support from California’s Stem Cell Agency
June 28, 2018
California’s Stem Cell Agency Invests in Research Developing New Treatments for Parkinson’s and Brain Tumors
California’s Stem Cell Agency Invests in Research Developing New Treatments for Parkinson’s and Brain Tumors
May 10, 2018
California’s Stem Cell Agency Applauds FDA for Crackdown on Stem Cell Clinics that “Peddle Unapproved Treatments.”
California’s Stem Cell Agency Applauds FDA for Crackdown on Stem Cell Clinics that “Peddle Unapproved Treatments.”
April 26, 2018
CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
April 26, 2018
CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
April 26, 2018
CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
CIRM President/CEO Presenting at Vatican Conference Targeting Cures for Deadly Diseases
April 5, 2018
CIRM Launches Industry Alliance Program to Facilitate Partnerships That Advance Stem Cell Therapies
CIRM Launches Industry Alliance Program to Facilitate Partnerships That Advance Stem Cell Therapies
April 4, 2018
Stem Cell Agency-Funded Clinical Trial for Age-Related Macular Degeneration Shows Encouraging Results
Stem Cell Agency-Funded Clinical Trial for Age-Related Macular Degeneration Shows Encouraging Results
February 22, 2018
California’s Stem Cell Agency Invests in Stem Cell-Based Therapies Targeting Sickle Cell Disease and Cancer
California’s Stem Cell Agency Invests in Stem Cell-Based Therapies Targeting Sickle Cell Disease and Cancer
January 18, 2018
California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients
California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients
January 17, 2018
Tireless Patient Advocate for California’s Stem Cell Agency to be Honored at World Stem Cell Summit
Tireless Patient Advocate for California’s Stem Cell Agency to be Honored at World Stem Cell Summit
December 14, 2017
Research Targeting Diabetes, Liver Failure and HIV Get Support from California Stem Cell Agency
Research Targeting Diabetes, Liver Failure and HIV Get Support from California Stem Cell Agency
November 30, 2017
California Stem Cell Agency Invests $16.4 Million to Test Great New Ideas Targeting Cancer, Vision Loss and Parkinson’s Disease.
California Stem Cell Agency Invests $16.4 Million to Test Great New Ideas Targeting Cancer, Vision Loss and Parkinson’s Disease.
October 26, 2017
Clinical Trials for Osteoarthritis, Multiple Myeloma and Making Bone Marrow Transplants Safer Get Go-ahead from Stem Cell Agency Board.
Clinical Trials for Osteoarthritis, Multiple Myeloma and Making Bone Marrow Transplants Safer Get Go-ahead from Stem Cell Agency Board.
October 2, 2017
Asterias Biotherapeutics announces positive 12-month results for CIRM-funded spinal cord injury trial
Asterias Biotherapeutics announces positive 12-month results for CIRM-funded spinal cord injury trial
September 28, 2017
California Stem Cell Agency Appoints New President and Invests in Additional Alpha Clinics and Clinical Trials Targeting Cancer, Diabetes and Kidney Disease
California Stem Cell Agency Appoints New President and Invests in Additional Alpha Clinics and Clinical Trials Targeting Cancer, Diabetes and Kidney Disease
August 24, 2017
Stem Cell Agency Invests in Clinical Trial that Uses a One-Two Punch to Confuse and Kill Leukemia Cells
Stem Cell Agency Invests in Clinical Trial that Uses a One-Two Punch to Confuse and Kill Leukemia Cells
July 20, 2017
Phase 3 Clinical Trial Targeting Lou Gehrig’s Disease Gets $15.9 Million Investment From Stem Cell Agency
Phase 3 Clinical Trial Targeting Lou Gehrig’s Disease Gets $15.9 Million Investment From Stem Cell Agency
June 29, 2017
Stem Cell Agency invests more than $44 million in treatments for stroke and fixing blood disorders in the womb
Stem Cell Agency invests more than $44 million in treatments for stroke and fixing blood disorders in the womb
June 12, 2017
Baseball’s Loss is Stem Cell Agency’s Gain as Stanford’s Linda Boxer Appointed to CIRM Board
Baseball’s Loss is Stem Cell Agency’s Gain as Stanford’s Linda Boxer Appointed to CIRM Board
April 7, 2017
CIRM-Funded Program Targeting Vision Loss Gets Investment Boost from Japanese Pharmaceutical Company
CIRM-Funded Program Targeting Vision Loss Gets Investment Boost from Japanese Pharmaceutical Company
March 23, 2017
A Stem Cell Library to Predict Which Drugs Are Heart Safe, and an Injectable Treatment for Clogged Arteries
A Stem Cell Library to Predict Which Drugs Are Heart Safe, and an Injectable Treatment for Clogged Arteries
February 23, 2017
Stem Cell Agency invests in clinical trials for life-threatening childhood diseases and a fatal brain disorder
Stem Cell Agency invests in clinical trials for life-threatening childhood diseases and a fatal brain disorder
January 19, 2017
Research to cure fatal childhood disease, combat Zika and slow Parkinson’s get go-ahead from Stem Cell Agency Board
Research to cure fatal childhood disease, combat Zika and slow Parkinson’s get go-ahead from Stem Cell Agency Board
December 13, 2016
Clinical Trials to Help Kidney Transplant Patients and Defeat Blindness Get Support from Stem Cell Agency Board
Clinical Trials to Help Kidney Transplant Patients and Defeat Blindness Get Support from Stem Cell Agency Board
December 5, 2016
Alzheimer’s, Sickle Cell Anemia, Cartilage and Bone Disorders Get $15 Million Research Boost from Stem Cell Agency
Alzheimer’s, Sickle Cell Anemia, Cartilage and Bone Disorders Get $15 Million Research Boost from Stem Cell Agency
November 28, 2016
CIRM-Funded Clinical Trial for Degenerative Eye Disease Finishes Patient Enrollment
CIRM-Funded Clinical Trial for Degenerative Eye Disease Finishes Patient Enrollment
